An AI Platform for Designing Personalized Neoantigen Vaccines Which Induce Polyepitopic Immune Responses

Time: 10:30 am
day: Day Two


  • Overview of a unique neoantigen discovery AI platform which integrates diverse experimental and prediction evidence
  • Evaluating the immunogenicty of predicted neoantigens in a preclinical setting
  • Demonstrating the induction of long-lasting, polyepitopic T-cell responses from personalized neoantigen vaccines in the ongoing TG4050 clinical trial